Recombinant expression of ecto-nucleotide pyrophosphatase/phosphodiesterase 4 (NPP4) and development of a luminescence-based assay to identify inhibitors-Reference-Cited by-同舟云学术

Recombinant expression of ecto-nucleotide pyrophosphatase/phosphodiesterase 4 (NPP4) and development of a luminescence-based assay to identify inhibitors

Published:2020-08 Issue: Volume:603 Page:113774
ISSN:0003-2697
Container-title:Analytical Biochemistry
language:en
Short-container-title:Analytical Biochemistry

Author:

Lopez Vittoria^ORCID,Lee Sang-Yong,Stephan Holger,Müller Christa E.

Funder

Federal Ministry of Education and Research (BMBF

Deutsche Forschungsgemeinschaft (DFG

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference25 articles.

1. Pathophysiology and therapeutic potential of purinergic signalling;Burnstock;Pharmacol. Rev.,2006

2. Cellular function and molecular structure of ecto-nucleotidases;Zimmermann;Purinergic Signal.,2012

3. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy;Abbracchio;Pharmacol. Rev.,2006

4. Activation and regulation of purinergic P2X receptor channels;Coddou;Pharmacol. Rev.,2011

5. The purinergic system as a pharmacological target for the treatment of immune-mediated inflammatory diseases;Antonioli;Pharmacol. Rev.,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) – a promising target for the immunotherapy of cancer;Frontiers in Immunology;2023-08-29

2. Effects of physical exercise on the functionality of human nucleotidases: A systematic review;Physiological Reports;2022-09

3. Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39 – a promising target for cancer immunotherapy;Journal for ImmunoTherapy of Cancer;2022-08

4. Beyond Triphosphates: Reagents and Methods for Chemical Oligophosphorylation;Journal of the American Chemical Society;2022-04-26

5. Nucleotide pyrophosphatase/phosphodiesterases (NPPs) including NPP1 and NPP2/ ATX as important drug targets: A patent review (2015-2020);Expert Opinion on Therapeutic Patents;2022-04-12